VIRGINIA RETIREMENT SYSTEMS ET Al Buys 30,400 Shares of Cencora, Inc. $COR

01 Nov 2026, 10:33 by Kim Johansen · The Markets Daily

VIRGINIA RETIREMENT SYSTEMS ET Al raised its position in Cencora, Inc. (NYSE:COR – Free Report) by 45.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 96,833 shares of the company’s stock after purchasing an additional 30,400 shares during the quarter. VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings in Cencora were worth $29,074,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Parcion Private Wealth LLC grew its position in Cencora by 5.7% in the third quarter. Parcion Private Wealth LLC now owns 1,161 shares of the company’s stock valued at $349,000 after purchasing an additional 63 shares in the last quarter. Partners Wealth Management LLC bought a new position in shares of Cencora in the 3rd quarter valued at about $258,000. Childress Capital Advisors LLC acquired a new stake in shares of Cencora in the third quarter valued at about $437,000. D.A. Davidson & CO. increased its position in shares of Cencora by 4.1% in the third quarter. D.A. Davidson & CO. now owns 1,780 shares of the company’s stock valued at $535,000 after acquiring an additional 70 shares during the last quarter. Finally, Motley Fool Asset Management LLC bought a new stake in Cencora during the third quarter worth about $4,071,000. 97.52% of the stock is currently owned by institutional investors.

Cencora Stock Up 0.1%

Cencora stock opened at $330.70 on Friday. The company has a debt-to-equity ratio of 3.53, a current ratio of 0.93 and a quick ratio of 0.58. The company’s 50-day moving average is $323.34 and its 200-day moving average is $317.53. The firm has a market capitalization of $63.11 billion, a PE ratio of 24.57, a P/E/G ratio of 1.69 and a beta of 0.58. Cencora, Inc. has a fifty-two week low of $244.82 and a fifty-two week high of $377.54.

Cencora (NYSE:COR – Get Free Report) last issued its earnings results on Wednesday, August 5th. The company reported $4.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.35 by $0.13. Cencora had a net margin of 0.79% and a return on equity of 125.45%. The business had revenue of $84.75 billion during the quarter, compared to the consensus estimate of $84.31 billion. During the same period last year, the business posted $4.00 EPS. Cencora’s revenue was up 5.1% on a year-over-year basis. Sell-side analysts anticipate that Cencora, Inc. will post 17.87 earnings per share for the current year.

Cencora Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, August 31st. Shareholders of record on Friday, August 14th were given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Friday, August 14th. Cencora’s payout ratio is 17.83%.

Insider Transactions at Cencora

In other Cencora news, EVP Elizabeth Campbell sold 11,300 shares of the company’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $324.12, for a total value of $3,662,556.00. Following the sale, the executive vice president owned 19,455 shares in the company, valued at $6,305,754.60. This represents a 36.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.38% of the stock is owned by corporate insiders.

Analyst Ratings Changes

COR has been the subject of several recent research reports. Leerink Partners increased their price target on Cencora from $380.00 to $388.00 and gave the company an “outperform” rating in a research report on Wednesday, October 7th. Wall Street Zen raised Cencora from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. UBS Group dropped their price objective on Cencora from $430.00 to $400.00 and set a “buy” rating on the stock in a research note on Friday, October 16th. Wells Fargo & Company increased their price objective on Cencora from $331.00 to $395.00 and gave the company an “overweight” rating in a report on Tuesday, August 11th. Finally, Citigroup reissued a “buy” rating on shares of Cencora in a report on Thursday, August 6th. Fourteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $368.38.

Get Our Latest Stock Report on COR

Cencora Company Profile

(Free Report)

Cencora, formerly known as AmerisourceBergen, is a global pharmaceutical sourcing and distribution company. It provides branded, generic and specialty pharmaceuticals, over-the-counter products and related health care supplies to pharmacies, hospitals, health systems, physician practices and other health care providers.